Recent Quarter Total Invested
$1.87 M
Recent Quarter Institutional Ownership Percentage
10.85%
Total Invested of Last Quarter
$303,946
Ownership Percentage of Last Quarter
1.09%
NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 1.58 M | $1.77 M | 100.00% | 10.28% |
| MEITAV INVESTMENT HOUSE LTD | 07/29/2024 | 40,000 | $44,800 | -20.00% | 0.26% |
| XTX TOPCO LTD | 08/12/2024 | 32,650 | $36,568 | 100.00% | 0.21% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 11,963 | $13,398 | 0.00% | 0.08% |
| MORGAN STANLEY | 10/17/2024 | 1,500 | $1,680 | 0.00% | 0.01% |
| CWM, LLC | 07/10/2024 | 1,000 | $1,000 | 0.00% | 0.01% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 54 | $60 | 0.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| WOODLINE PARTNERS LP | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
NeuroSense Therapeutics Ltd.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of NRSN shares?
During the previous two years, 7 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 1.58 M
XTX Topco Ltd: 32,650
GEODE CAPITAL MANAGEMENT, LLC: 11,963
MORGAN STANLEY: 1,500
Qube Research & Technologies Ltd: 54
UBS Group AG: 0
-
What percentage of NeuroSense Therapeutics Ltd. stock is owned by institutional investors?
10.85% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
-
How much institutional buying is happening at NRSN ?
Institutional investors have bought a total of 1.63 M shares in the last 24 months. This purchase volume represents approximately $2.17 M in transactions.